Patent · US Active

Vaccines against chlamydial infection

US8541007B2 · kind B2 · utility

3Cited by

9References

14Claims

0Family size

Assignees

GLAXOSMITHKLINE BIOLOGICALS SA · BE
CORIXA CORPORATION · US

Inventors

Mark Alderson · Bainbridge Island, US
Ajay Bhatia · Seattle, US
Yves Lobet · Rixensart, BE
Brenda Maisonneuve · Federal Way, US
Jean-Francois L. Maisonneuve · Federal Way, US
Martine Marchand · Rixensart, BE
Pascal Mettens · Rixensart, BE
Florence Bernadette Nozay · Rixensart, BE
Peter Probst · Seattle, US
Yasir Skeiky · Bellevue, US

Key dates

Filing date	Dec 21, 2010
Grant date	Sep 24, 2013
Priority date	—
Expiry date	Dec 21, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55577
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising proteins or polynucleotides of Chlamydia sp., in particular combinations of proteins or polynucleotides encoding them, and methods for the use of the proteins or polynucleotides in the treatment, prevention and diagnosis of Chlamydia infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.